Table 2. Multivariate Cox proportional hazard models for prediction of ESRD in different cohorts of patients who received and did not receive nephrouretectomies or AA.
N of subjects | N of ESRD | Person-years | Rate1 | Age, sex-adjusted HR (95% CI) | Model 1a | Model 2 | |
---|---|---|---|---|---|---|---|
All | |||||||
Comparison Group | 208136 | 1829 | 997339 | 1.83 | 1.00 | 1.00 | 1.00 |
UC (Total) | 26017 | 979 | 98929 | 9.90 | 5.46 (5.05–5.91)*** | 3.87 (3.57–4.19)*** | |
Without Nephrouretectomy | 21163 | 553 | 82887 | 6.67 | 3.72 (3.38-4.09)*** | 2.74 (2.48-3.01)*** | 2.76b (2.51-3.04)*** |
With Nephrouretectomy | 4854 | 426 | 16042 | 26.56 | 13.8 (12.4-15.4)*** | 8.88 (7.95-9.93)*** | |
Without AA | 21694 | 771 | 82188 | 9.38 | 5.19 (4.77-5.64)*** | 3.69 (3.38-4.02)*** | 3.18c (2.92-3.46)*** |
With AA | 4323 | 208 | 16740 | 12.43 | 6.78 (5.87-7.82)*** | 4.73 (4.09-5.46)*** | |
UT-UC | 4263 | 330 | 12515 | 16.37 | 13.5 (11.9–15.2)*** | 7.75 (6.84–8.78)*** | |
Without Nephrouretectomy | 957 | 73 | 2221 | 32.87 | 16.6 (13.1-21.0)*** | 7.07 (5.55-9.01)*** | 3.20b (2.65-3.86)*** |
With Nephrouretectomy | 3306 | 257 | 10294 | 24.97 | 13.0 (11.4-14.8)*** | 8.25 (7.20-9.45)*** | |
Without AA | 3326 | 250 | 9741 | 25.66 | 13.1 (11.5-15.0)*** | 7.75 (6.75-8.89)*** | 6.06c (5.32-6.91)*** |
With AA | 937 | 80 | 2774 | 28.84 | 14.6 (11.7-18.4)*** | 7.80 (6.20-9.82)*** | |
B-UC | 21537 | 642 | 85750 | 7.49 | 4.18 (3.82–4.57)*** | 3.12 (2.84–3.42)*** | |
Without Nephrouretectomy | 20029 | 475 | 80137 | 5.93 | 3.31 (2.99-3.66)*** | 2.50 (2.26-2.77)*** | 2.72b (2.47-3.00)*** |
With Nephrouretectomy | 1508 | 167 | 5613 | 29.75 | 15.9 (13.6-18.6)*** | 10.6 (8.99-12.4)*** | |
Without AA | 18184 | 516 | 71919 | 7.17 | 4.00 (3.62-4.41)*** | 2.97 (2.69-3.28)*** | 2.63c (2.39-2.90)*** |
With AA | 3353 | 126 | 13831 | 9.11 | 5.11 (4.26-6.12)*** | 3.89 (3.24-4.66)*** |
Rate per 1000 person-years
ESRD: end-stage renal disease, HR: hazard ratio.
Multivariate model adjusted for age, sex, geographic region, occupation, monthly income, and comorbidities (diabetes, hypertension, coronary heart disease, atrial fibrillation, heart failure, chronic kidney disease, and hyperlipidemia).
Add adjusted for nephrouretectomy in model 1.
Add adjusted for AA in model 1.